From an early age, children spend many hours interacting with screens: phones, tablets, and laptops. A new policy brief from the Child Health Policy Program explains the importance of unstructured free play for healthy child development and recommends four policy approaches to reduce screen time and ensure children’s well-being in the digital age.
Ann Lê, Katarina Reyes, Ethan T. Hunt, Christopher F. Kulesza, Zoabe HafeezApril 5, 2024
This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023
Economic security has become a top priority for the West following the disruptions caused by COVID-19, the Russia-Ukraine war and the growing threat of China. Could investing in brain capital help build more resilient economies?
William Hynes, Paweł Świeboda, Patrick Love, Jo-An Occhipinti, Harris A. EyreAugust 2, 2023
Precision psychiatry promises to more accurately diagnose and treat patients. Brain health experts call for European researchers, policymakers and industry to work together to advance the field and give Europe a competitive edge.
Marion Leboyer, Paweł Świeboda, Harris A. Eyre, Veronique Briquet-LaugierJune 5, 2023
Visiting scholar Osamah Alsayegh explores the water and energy challenges of GCC states and offers three key policy recommendations that could help to build the region’s resilience and sustainability.
Effective drug policy requires acceptance that, for better or worse, licit and illicit drug use is part of our world. The authors recommend several steps the federal government can take to facilitate more pragmatic and effective drug policy at all levels of government.
Katharine Neill Harris, William MartinFebruary 5, 2021
Given the advantages of an LLC and frequent advice to form one, the authors explore the reasons for the low adoption of the LLC form of business by entrepreneurs and ways to increase its use.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.
Repealing Obamacare and replacing it with market-based coverage that is both compassionate and prudent will make health care affordable again, which will guarantee access to insurance coverage for all Americans.
There is broad consensus in the medical and scientific community that substance abuse should be treated as a medical and public health problem, not a crime. The authors recommend a sensible pivot from failed policies of drug prohibition toward a realistic approach to drug use.
William Martin, Katharine Neill HarrisDecember 5, 2016